Source:http://linkedlifedata.com/resource/pubmed/id/19365154
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2009-5-14
|
pubmed:abstractText |
Effects of the cholinesterase inhibitors tacrine and bis(7)- tacrine (0.25-20 micromol/kg, s.c.) on locomotor activity and passive-avoidance response were investigated in mice treated with scopolamine (SCP, 1 or 5 micromol/kg, i.p.), using an open-field test and step-through task with a 24-hour retention interval. Drugs were given 30 min prior to the first session. During the acquisition session, SCP treatment increased the locomotor activity (10-16%). Tacrine, but not bis(7)-tacrine, cotreatment significantly reduced the locomotor activity by 23 or 27%, when compared with the SCP-treated control mice. In the step-through task, tacrine or bis(7)-tacrine coadministration dose-dependently attenuated the increase in the number of footshocks (by 50 or 58%) in SCP-treated mice. The lowest dose of tacrine and bis(7)-tacrine for prolonging the retention latency (up to 500%) in SCP-treated mice was 5 and 1 micromol/kg, respectively. Tacrine and bis(7)-tacrine inhibited brain acetylcholinesterase (AChE) activity 15 min (but not 30 min) after the drug administration in mice. At the same dose of 20 micromol/kg, the bis(7)-tacrine-induced AChE inhibition in serum was 14-fold higher than that of tacrine. The results indicated that bis(7)-tacrine was less potent than tacrine in causing motor dysfunction. However, bis(7)-tacrine was more potent than tacrine in the cognitive enhancement of SCP-induced memory loss and in AChE inhibition.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1,7-N-heptylene-bis-9,9'-amino-1,2,3...,
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholinesterase,
http://linkedlifedata.com/resource/pubmed/chemical/Cholinesterase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Scopolamine Hydrobromide,
http://linkedlifedata.com/resource/pubmed/chemical/Tacrine
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1423-0313
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2009 S. Karger AG, Basel.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
294-300
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:19365154-Acetylcholinesterase,
pubmed-meshheading:19365154-Animals,
pubmed-meshheading:19365154-Avoidance Learning,
pubmed-meshheading:19365154-Brain,
pubmed-meshheading:19365154-Cholinesterase Inhibitors,
pubmed-meshheading:19365154-Dose-Response Relationship, Drug,
pubmed-meshheading:19365154-Drug Interactions,
pubmed-meshheading:19365154-Male,
pubmed-meshheading:19365154-Mice,
pubmed-meshheading:19365154-Mice, Inbred ICR,
pubmed-meshheading:19365154-Motor Activity,
pubmed-meshheading:19365154-Scopolamine Hydrobromide,
pubmed-meshheading:19365154-Tacrine
|
pubmed:year |
2009
|
pubmed:articleTitle |
Comparison studies of tacrine and bis7-tacrine on the suppression of scopolamine-induced behavioral changes and inhibition of acetylcholinesterase in mice.
|
pubmed:affiliation |
Department of Pharmacology, Beijing University of Chinese Medicine, Beijing, SAR, China. siyuan-pan@163.com
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|